Imperva, Inc. (NASDAQ:IMPV) has been given a consensus rating of “Hold” by the twenty analysts that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $52.38.
IMPV has been the subject of several analyst reports. Evercore ISI set a $56.00 target price on Imperva and gave the stock a “buy” rating in a report on Thursday, August 10th. Monness Crespi & Hardt boosted their target price on Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Piper Jaffray Companies set a $58.00 target price on Imperva and gave the stock a “buy” rating in a report on Monday, August 28th. Royal Bank Of Canada restated a “buy” rating and issued a $49.00 target price on shares of Imperva in a report on Wednesday, October 18th. Finally, Oppenheimer Holdings, Inc. restated a “buy” rating and issued a $55.00 target price on shares of Imperva in a report on Thursday, November 9th.
In other Imperva news, Director Anthony J. Bettencourt sold 99,598 shares of Imperva stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.90% of the company’s stock.
Shares of Imperva (NASDAQ:IMPV) traded up $0.15 during trading on Friday, hitting $40.45. The stock had a trading volume of 235,700 shares, compared to its average volume of 441,399. Imperva has a fifty-two week low of $35.45 and a fifty-two week high of $52.40.
Imperva (NASDAQ:IMPV) last announced its quarterly earnings results on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million during the quarter, compared to analyst estimates of $83.79 million. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The firm’s revenue was up 22.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.08 EPS. sell-side analysts anticipate that Imperva will post -0.52 earnings per share for the current year.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
What are top analysts saying about Imperva Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva Inc. and related companies.